NHS National Proprietary Pharmaceuticals
key details
| Value | £1,500,000,000 |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 |
| Contract start | 1 May 2026 |
| Contract end | 30 Apr 2028 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-f8920c60-a706-445b-a385-9bdb3b49a22f |
description
NHS National Proprietary Pharmaceuticals
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 8 Dec 2022 | Planning (planning) | · | c02e645c-009b-4a09-8923-f38db03ba40d-597223 |
| 9 May 2023 | Planning (planning) | · | 5a6cb151-6262-469b-9b52-d95a05167646-643168 |
more from NHS ENGLAND
- Market Engagement Event for East ofEngland prisons · £0 · 11 Sept 2026
- Finance Transformation & Enablement Project Support · £7,944,879 · 10 Sept 2026
- Provision of Public Consultation and Engagement Services for the UISPC · £155,000 · 8 Sept 2026
- Targeted Lung Health Checks National Licences · £1,900,000 · 8 Sept 2026
- Adult Screening and Personalisation Digital Delivery Services · £215,163,316 · 4 Sept 2026
- Step into the NHS - Schools Programme · £65,800 · 2 Sept 2026
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk · £168,336 · 1 Sept 2026
- NHS Login Run and Maintain 2 · £30,000,000 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.